MGLIX | MGLRX | MGLIX / MGLRX | |
Total Expense Ratio | 0.94 | 0.85 | 111% |
Annual Report Gross Expense Ratio | 0.95 | 0.86 | 110% |
Fund Existence | 16 years | 13 years | - |
Gain YTD | 3.616 | 3.669 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 2.22B | 100% |
Annual Yield % from dividends | 2.51 | 2.59 | 97% |
Returns for 1 year | 2.42 | 2.49 | 97% |
Returns for 3 years | -3.43 | -3.83 | 90% |
Returns for 5 years | 15.01 | 14.75 | 102% |
Returns for 10 years | 32.21 | 32.52 | 99% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMVX | 18.42 | 0.15 | +0.82% |
Voya Mid Cap Research Enhanced Index R | |||
OPTFX | 90.47 | 0.55 | +0.61% |
Invesco Discovery Large Cap A | |||
MUIGX | 17.56 | 0.07 | +0.40% |
Nationwide BNY Mellon Dyn US Core R6 | |||
GCVRX | 24.29 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R | |||
LHCTX | 18.56 | 0.05 | +0.27% |
Lord Abbett Health Care R5 |